Abstract
Objective: Stroke is common (100 000 new cases annually in the UK), with carotid atherosclerotic disease a recognised cause.1 In such cases patients may require either surgical or endovascular carotid intervention but they should also receive optimal medical therapy including lipid lowering therapy (LLT).2 Statins have been shown to reduce the 10 year risk of stroke/death (17.9% vs. 7.6%) after carotid endarterectomy.3 Current European Society for Vascular Surgery (ESVS) Guidelines advise high intensity statin (HIS) treatment with a target LDL C level of < 1.8 mmol/L.2 This study aims to explores trends in titration of lipid lowering therapy and LDL C levels in patients undergoing carotid intervention prior to, at the time of, and one year following carotid intervention.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Vascular and Endovascular Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
